glp-1 video What is a agonist, and how does it work? Clear medicine liquid inside glass

Style gently

Tirzepatide is an approved GLP-1R/GIP dual agonist developed by Eli Lilly, garnering significant attention alongside SEMA in the field of T2DM and weight loss

Alruwaili H, Dehestani B, le Roux CW (2021) Clinical impact of liraglutide as a treatment of obesity

Given that Mounjaro became the best-selling drug in Indian history, and has a better weight-loss profile than Sema (with similar side effects), Im confident the same dynamic will play out in the UK and US when semaglutide goes off patent in 2032

Lixisenatide is effective and safe as add-on treatment to basal insulin in Asian individuals with type 2 diabetes and different body mass indices: A pooled analysis of data from the GetGoal Studies

Fatigue: Its normal to feel a bit sluggish at first as your body adapts to a new metabolic rhythm